Evoke Pharma Inc
EVOKDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted in 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Evoke Pharma Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EVOK is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 15
- +5 vs. Q2 2025
- Shares held
- 590.7K
- +358.7K (+154.6%) vs. Q2 2025
- Total value
- $2.94M
- +$2.33M (+386.6%) vs. Q2 2025
- New holders
- 7
- 4 more added
- Sold out
- 2
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 15 | $2.94M |
| Q2 2025 | 10 | $603.6K |
| Q1 2025 | 10 | $678.2K |
| Q4 2024 | 8 | $965.6K |
| Q3 2024 | 12 | $994.6K |
| Q2 2024 | 16 | $2.02M |
| Q1 2024 | 15 | $1.93M |
| Q4 2023 | 11 | $72.2K |
| Q3 2023 | 11 | $92.4K |
| Q2 2023 | 11 | $97.4K |
| Q1 2023 | 12 | $131.1K |
| Q4 2022 | 12 | $161.2K |
| Q3 2022 | 11 | $117.0K |
| Q2 2022 | 13 | $228.0K |
| Q1 2022 | 22 | $987.0K |
| Q4 2021 | 25 | $1.13M |
| Q3 2021 | 23 | $5.46M |
| Q2 2021 | 22 | $6.17M |
| Q1 2021 | 25 | $7.83M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Evoke Pharma Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 159,358 | $792.0K | 0.00% | +159,294+248,896.9% | Added |
| Nantahala Capital Management, LLC | 148,153 | $736.3K | 0.05% | 00.0% | Unchanged |
| Bleichroeder LP | 146,395 | $727.6K | 0.14% | +77,645+112.9% | Added |
| National Wealth Management Group, LLC | 80,130 | $398.2K | 0.15% | +80,130 | New |
| DRW Securities, LLC | 23,742 | $118.0K | 0.01% | +23,742 | New |
| Vanguard Group Inc | 18,759 | $93.2K | 0.00% | +18,759 | New |
| Two Sigma Securities, LLC | 10,437 | $51.9K | 0.01% | +10,437 | New |
| Advisor Group Holdings, Inc. | 3,010 | $16.4K | 0.00% | +3,010 | New |
| Northwestern Mutual Wealth Management Co | 272 | $1.35K | 0.00% | +272 | New |
| Royal Bank of Canada | 190 | $1.00K | 0.00% | +190 | New |
| BlackRock, Inc. | 122 | $606 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 76 | $378 | 0.00% | +1+1.3% | Added |
| Tower Research Capital LLC (TRC) | 40 | $199 | 0.00% | −1,948−98.0% | Reduced |
| GWM Advisors LLC | 17 | $84 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12 | $60 | 0.00% | +2+20.0% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,542−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −301−100.0% | Sold out |